Cargando…

Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials

OBJECTIVES: The perioperative, functional, and oncological outcomes of patients with solitary small renal tumors (SRMs) treated with ablation (AT) or partial nephrectomy (PN) remain controversial. The aim of this study was to compare the outcomes of these two surgical techniques. METHODS: In April 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Zhi, Wang, Li, Huang, Jing, Liu, Yang, Chen, Cai-xia, Wang, Chong-jian, Chen, Lin-lin, Yang, Xue-song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331136/
https://www.ncbi.nlm.nih.gov/pubmed/37434978
http://dx.doi.org/10.3389/fonc.2023.1202587
_version_ 1785070197161328640
author Wen, Zhi
Wang, Li
Huang, Jing
Liu, Yang
Chen, Cai-xia
Wang, Chong-jian
Chen, Lin-lin
Yang, Xue-song
author_facet Wen, Zhi
Wang, Li
Huang, Jing
Liu, Yang
Chen, Cai-xia
Wang, Chong-jian
Chen, Lin-lin
Yang, Xue-song
author_sort Wen, Zhi
collection PubMed
description OBJECTIVES: The perioperative, functional, and oncological outcomes of patients with solitary small renal tumors (SRMs) treated with ablation (AT) or partial nephrectomy (PN) remain controversial. The aim of this study was to compare the outcomes of these two surgical techniques. METHODS: In April 2023, we conducted a literature search in several widely used databases worldwide, including PubMed, Embase, and Google Scholar. Review Manager was used to compare various parameters. The study was registered with PROSPERO (CRD42022377157). RESULTS: Our final meta-analysis included 13 cohort studies with a total of 2,107 patients. Compared to partial nephrectomy (PN), ablation (AT) had shorter hospital stays (WMD -2.37 days, 95% CI -3.05 to -1.69; p < 0.00001), shorter operating times (WMD -57.06 min, 95% CI -88.92 to -25.19; p = 0.0004), less postoperative creatinine increases (WMD -0.17 mg/dL, 95% CI -0.29 to -0.05; p = 0.006), less postoperative glomerular filtration rate decreases (WMD -9.84 mL/min/1.73 m2, 95% CI -14.25 to -5.44; p < 0.0001), less postoperative new-onset chronic kidney disease (OR 0.33, 95% CI 0.16 to 0.71; p = 0.005), and less intraoperative blood loss (WMD -285.92 ml, 95% CI -428.44 to -143.40; p < 0.0001). The transfusion rate was lower in the ablation group (OR 0.17, 95% CI 0.06 to 0.51; p = 0.001). The risk of local recurrence was higher in the ablation group (OR 2.96, 95% CI 1.27 to 6.89; p = 0.01), while the risk of distant metastasis was higher in the partial nephrectomy group (OR 2.81, 95% CI 1.28 to 6.18; p = 0.01). The intraoperative and postoperative complication rates were lower in the ablation group (OR 0.23, 95% CI 0.08 to 0.62; p = 0.004 and OR 0.21, 95% CI 0.11 to 0.38; p < 0.00001, respectively). However, overall survival, postoperative dialysis rate, and tumor-specific survival were not different between the two groups. CONCLUSIONS: Our data suggest that ablation and partial nephrectomy are equally safe and effective in the treatment of small solitary kidney tumors and are better options for patients with poor preoperative physical condition or poor renal function.
format Online
Article
Text
id pubmed-10331136
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103311362023-07-11 Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials Wen, Zhi Wang, Li Huang, Jing Liu, Yang Chen, Cai-xia Wang, Chong-jian Chen, Lin-lin Yang, Xue-song Front Oncol Oncology OBJECTIVES: The perioperative, functional, and oncological outcomes of patients with solitary small renal tumors (SRMs) treated with ablation (AT) or partial nephrectomy (PN) remain controversial. The aim of this study was to compare the outcomes of these two surgical techniques. METHODS: In April 2023, we conducted a literature search in several widely used databases worldwide, including PubMed, Embase, and Google Scholar. Review Manager was used to compare various parameters. The study was registered with PROSPERO (CRD42022377157). RESULTS: Our final meta-analysis included 13 cohort studies with a total of 2,107 patients. Compared to partial nephrectomy (PN), ablation (AT) had shorter hospital stays (WMD -2.37 days, 95% CI -3.05 to -1.69; p < 0.00001), shorter operating times (WMD -57.06 min, 95% CI -88.92 to -25.19; p = 0.0004), less postoperative creatinine increases (WMD -0.17 mg/dL, 95% CI -0.29 to -0.05; p = 0.006), less postoperative glomerular filtration rate decreases (WMD -9.84 mL/min/1.73 m2, 95% CI -14.25 to -5.44; p < 0.0001), less postoperative new-onset chronic kidney disease (OR 0.33, 95% CI 0.16 to 0.71; p = 0.005), and less intraoperative blood loss (WMD -285.92 ml, 95% CI -428.44 to -143.40; p < 0.0001). The transfusion rate was lower in the ablation group (OR 0.17, 95% CI 0.06 to 0.51; p = 0.001). The risk of local recurrence was higher in the ablation group (OR 2.96, 95% CI 1.27 to 6.89; p = 0.01), while the risk of distant metastasis was higher in the partial nephrectomy group (OR 2.81, 95% CI 1.28 to 6.18; p = 0.01). The intraoperative and postoperative complication rates were lower in the ablation group (OR 0.23, 95% CI 0.08 to 0.62; p = 0.004 and OR 0.21, 95% CI 0.11 to 0.38; p < 0.00001, respectively). However, overall survival, postoperative dialysis rate, and tumor-specific survival were not different between the two groups. CONCLUSIONS: Our data suggest that ablation and partial nephrectomy are equally safe and effective in the treatment of small solitary kidney tumors and are better options for patients with poor preoperative physical condition or poor renal function. Frontiers Media S.A. 2023-06-26 /pmc/articles/PMC10331136/ /pubmed/37434978 http://dx.doi.org/10.3389/fonc.2023.1202587 Text en Copyright © 2023 Wen, Wang, Huang, Liu, Chen, Wang, Chen and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wen, Zhi
Wang, Li
Huang, Jing
Liu, Yang
Chen, Cai-xia
Wang, Chong-jian
Chen, Lin-lin
Yang, Xue-song
Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials
title Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials
title_full Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials
title_fullStr Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials
title_full_unstemmed Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials
title_short Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials
title_sort perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331136/
https://www.ncbi.nlm.nih.gov/pubmed/37434978
http://dx.doi.org/10.3389/fonc.2023.1202587
work_keys_str_mv AT wenzhi perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials
AT wangli perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials
AT huangjing perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials
AT liuyang perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials
AT chencaixia perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials
AT wangchongjian perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials
AT chenlinlin perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials
AT yangxuesong perioperativefunctionalandoncologicoutcomesafterablationorpartialnephrectomyforsolitaryrenaltumorsasystematicreviewandmetaanalysisofcomparativetrials